MLC 901

DRUG2 trials

Sponsors

Shahid Beheshti University of Medical Sciences, Moleac Pte Ltd.

Conditions

Alzheimer's Disease DementiaHypoxic Ischaemic Encephalopathy Due to Cardiac Arrest

Early Phase 1

MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial

CompletedNCT05621590

Shahid Beheshti University of Medical SciencesHypoxic Ischaemic Encephalopathy Due to Cardiac Arrest

Start: 2020-03-10End: 2022-08-12Updated: 2022-11-18

Phase 3

Alzheimer's Disease THErapy With NEuroaid II

Not yet recruitingNCT07191028

Moleac Pte Ltd.Alzheimer's Disease Dementia

Start: 2026-08-01End: 2029-05-01Target: 350Updated: 2026-06-12